Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape

We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of <i>Pseudomonas aeruginosa</i> exotoxin A and...

Full description

Bibliographic Details
Main Authors: Elena Shramova, Galina Proshkina, Victoria Shipunova, Anastasia Ryabova, Roman Kamyshinsky, Andrey Konevega, Aleksey Schulga, Elena Konovalova, Georgij Telegin, Sergey Deyev
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3014
_version_ 1797550645384839168
author Elena Shramova
Galina Proshkina
Victoria Shipunova
Anastasia Ryabova
Roman Kamyshinsky
Andrey Konevega
Aleksey Schulga
Elena Konovalova
Georgij Telegin
Sergey Deyev
author_facet Elena Shramova
Galina Proshkina
Victoria Shipunova
Anastasia Ryabova
Roman Kamyshinsky
Andrey Konevega
Aleksey Schulga
Elena Konovalova
Georgij Telegin
Sergey Deyev
author_sort Elena Shramova
collection DOAJ
description We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of <i>Pseudomonas aeruginosa</i> exotoxin A and ribonuclease Barnase from <i>Bacillus amyloliquefaciens</i>. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy.
first_indexed 2024-03-10T15:33:17Z
format Article
id doaj.art-352cc5239f1c45bd852ddd13d6c7f404
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:33:17Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-352cc5239f1c45bd852ddd13d6c7f4042023-11-20T17:26:50ZengMDPI AGCancers2072-66942020-10-011210301410.3390/cancers12103014Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor EscapeElena Shramova0Galina Proshkina1Victoria Shipunova2Anastasia Ryabova3Roman Kamyshinsky4Andrey Konevega5Aleksey Schulga6Elena Konovalova7Georgij Telegin8Sergey Deyev9Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaProkhorov General Physics Institute, Russian Academy of Sciences, Vavilova Street 38, 119991 Moscow, RussiaNational Research Center “Kurchatov Institute”, Akademika Kurchatova pl. 1, 123182 Moscow, RussiaNational Research Center “Kurchatov Institute”, Akademika Kurchatova pl. 1, 123182 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho–Maklaya Street 16/10, 117997 Moscow, RussiaWe report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of <i>Pseudomonas aeruginosa</i> exotoxin A and ribonuclease Barnase from <i>Bacillus amyloliquefaciens</i>. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy.https://www.mdpi.com/2072-6694/12/10/3014BarnaseliposomesHER2EpCAMcancer therapy
spellingShingle Elena Shramova
Galina Proshkina
Victoria Shipunova
Anastasia Ryabova
Roman Kamyshinsky
Andrey Konevega
Aleksey Schulga
Elena Konovalova
Georgij Telegin
Sergey Deyev
Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
Cancers
Barnase
liposomes
HER2
EpCAM
cancer therapy
title Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
title_full Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
title_fullStr Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
title_full_unstemmed Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
title_short Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
title_sort dual targeting of cancer cells with darpin based toxins for overcoming tumor escape
topic Barnase
liposomes
HER2
EpCAM
cancer therapy
url https://www.mdpi.com/2072-6694/12/10/3014
work_keys_str_mv AT elenashramova dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT galinaproshkina dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT victoriashipunova dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT anastasiaryabova dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT romankamyshinsky dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT andreykonevega dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT alekseyschulga dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT elenakonovalova dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT georgijtelegin dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape
AT sergeydeyev dualtargetingofcancercellswithdarpinbasedtoxinsforovercomingtumorescape